nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—NOS1—Doxorubicin—muscle cancer	0.339	0.429	CbGbCtD
L-Citrulline—NOS2—Doxorubicin—muscle cancer	0.225	0.285	CbGbCtD
L-Citrulline—NOS3—Doxorubicin—muscle cancer	0.225	0.285	CbGbCtD
L-Citrulline—NOS1—Effects of Nitric Oxide—MB—muscle cancer	0.0249	0.256	CbGpPWpGaD
L-Citrulline—NOS2—Effects of Nitric Oxide—MB—muscle cancer	0.0188	0.193	CbGpPWpGaD
L-Citrulline—NOS3—Effects of Nitric Oxide—MB—muscle cancer	0.0146	0.15	CbGpPWpGaD
L-Citrulline—PADI6—Preimplantation Embryo—HMGA1—muscle cancer	0.00751	0.0771	CbGpPWpGaD
L-Citrulline—NOS3—hindlimb—muscle cancer	0.00722	0.0636	CbGeAlD
L-Citrulline—NOS3—appendage—muscle cancer	0.00619	0.0545	CbGeAlD
L-Citrulline—PADI3—renal system—muscle cancer	0.00543	0.0478	CbGeAlD
L-Citrulline—PADI1—vagina—muscle cancer	0.00471	0.0415	CbGeAlD
L-Citrulline—NOS2—tendon—muscle cancer	0.0044	0.0388	CbGeAlD
L-Citrulline—PADI1—head—muscle cancer	0.00435	0.0383	CbGeAlD
L-Citrulline—PADI3—vagina—muscle cancer	0.00393	0.0346	CbGeAlD
L-Citrulline—PADI4—bone marrow—muscle cancer	0.00384	0.0338	CbGeAlD
L-Citrulline—PADI3—head—muscle cancer	0.00363	0.032	CbGeAlD
L-Citrulline—PADI4—head—muscle cancer	0.0034	0.0299	CbGeAlD
L-Citrulline—DDAH1—smooth muscle tissue—muscle cancer	0.00318	0.028	CbGeAlD
L-Citrulline—DDAH1—renal system—muscle cancer	0.00306	0.027	CbGeAlD
L-Citrulline—OTC—head—muscle cancer	0.00298	0.0263	CbGeAlD
L-Citrulline—PADI2—tendon—muscle cancer	0.00296	0.0261	CbGeAlD
L-Citrulline—OTC—testis—muscle cancer	0.00288	0.0254	CbGeAlD
L-Citrulline—PADI2—bone marrow—muscle cancer	0.00287	0.0252	CbGeAlD
L-Citrulline—DDAH2—cardiac atrium—muscle cancer	0.00284	0.0251	CbGeAlD
L-Citrulline—PADI2—head—muscle cancer	0.00254	0.0223	CbGeAlD
L-Citrulline—DDAH2—tendon—muscle cancer	0.00248	0.0218	CbGeAlD
L-Citrulline—PADI2—testis—muscle cancer	0.00245	0.0216	CbGeAlD
L-Citrulline—DDAH2—bone marrow—muscle cancer	0.0024	0.0212	CbGeAlD
L-Citrulline—DDAH1—tendon—muscle cancer	0.00239	0.0211	CbGeAlD
L-Citrulline—DDAH2—vagina—muscle cancer	0.0023	0.0203	CbGeAlD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—muscle cancer	0.00222	0.0228	CbGpPWpGaD
L-Citrulline—NOS1—smooth muscle tissue—muscle cancer	0.00213	0.0187	CbGeAlD
L-Citrulline—DDAH2—testis—muscle cancer	0.00205	0.0181	CbGeAlD
L-Citrulline—DDAH1—head—muscle cancer	0.00205	0.0181	CbGeAlD
L-Citrulline—NOS1—renal system—muscle cancer	0.00205	0.018	CbGeAlD
L-Citrulline—DDAH1—testis—muscle cancer	0.00198	0.0174	CbGeAlD
L-Citrulline—NOS1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—muscle cancer	0.00181	0.0186	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ANGPT2—muscle cancer	0.00168	0.0172	CbGpPWpGaD
L-Citrulline—NOS3—Angiopoietin receptor Tie2-mediated signaling—ANGPT2—muscle cancer	0.00164	0.0169	CbGpPWpGaD
L-Citrulline—ASS1—smooth muscle tissue—muscle cancer	0.00162	0.0143	CbGeAlD
L-Citrulline—NOS3—smooth muscle tissue—muscle cancer	0.00162	0.0142	CbGeAlD
L-Citrulline—NOS1—tendon—muscle cancer	0.0016	0.0141	CbGeAlD
L-Citrulline—ASS1—renal system—muscle cancer	0.00156	0.0138	CbGeAlD
L-Citrulline—NOS3—renal system—muscle cancer	0.00156	0.0137	CbGeAlD
L-Citrulline—NOS1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	0.00142	0.0146	CbGpPWpGaD
L-Citrulline—ASS1—cardiac atrium—muscle cancer	0.0014	0.0123	CbGeAlD
L-Citrulline—NOS1—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.00139	0.0143	CbGpPWpGaD
L-Citrulline—NOS1—head—muscle cancer	0.00137	0.0121	CbGeAlD
L-Citrulline—NOS1—testis—muscle cancer	0.00132	0.0117	CbGeAlD
L-Citrulline—ASS1—tendon—muscle cancer	0.00122	0.0107	CbGeAlD
L-Citrulline—NOS3—tendon—muscle cancer	0.00121	0.0107	CbGeAlD
L-Citrulline—ASS1—vagina—muscle cancer	0.00113	0.00996	CbGeAlD
L-Citrulline—NOS3—vagina—muscle cancer	0.00113	0.00993	CbGeAlD
L-Citrulline—ASS1—head—muscle cancer	0.00104	0.0092	CbGeAlD
L-Citrulline—NOS3—head—muscle cancer	0.00104	0.00917	CbGeAlD
L-Citrulline—NOS2—AGE/RAGE pathway—FOXO4—muscle cancer	0.00103	0.0105	CbGpPWpGaD
L-Citrulline—ASS1—testis—muscle cancer	0.00101	0.00889	CbGeAlD
L-Citrulline—NOS3—testis—muscle cancer	0.00101	0.00886	CbGeAlD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—muscle cancer	0.000994	0.0102	CbGpPWpGaD
L-Citrulline—NOS3—Myometrial Relaxation and Contraction Pathways—CALD1—muscle cancer	0.000816	0.00838	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—FOXO4—muscle cancer	0.000798	0.00819	CbGpPWpGaD
L-Citrulline—NOS2—AGE/RAGE pathway—FOXO1—muscle cancer	0.000759	0.00779	CbGpPWpGaD
L-Citrulline—NOS2—Alpha9 beta1 integrin signaling events—VEGFA—muscle cancer	0.000752	0.00772	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—FOXO1—muscle cancer	0.00075	0.0077	CbGpPWpGaD
L-Citrulline—NOS3—Angiopoietin receptor Tie2-mediated signaling—FOXO1—muscle cancer	0.000736	0.00755	CbGpPWpGaD
L-Citrulline—NOS2—Signaling mediated by p38-alpha and p38-beta—PTGS2—muscle cancer	0.000729	0.00749	CbGpPWpGaD
L-Citrulline—NOS3—Angiogenesis—VEGFA—muscle cancer	0.000603	0.00619	CbGpPWpGaD
L-Citrulline—NOS3—AGE/RAGE pathway—FOXO1—muscle cancer	0.000589	0.00605	CbGpPWpGaD
L-Citrulline—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—muscle cancer	0.000579	0.00595	CbGpPWpGaD
L-Citrulline—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.000539	0.00553	CbGpPWpGaD
L-Citrulline—NOS3—Leptin signaling pathway—FOXO1—muscle cancer	0.000532	0.00546	CbGpPWpGaD
L-Citrulline—NOS3—VEGFR1 specific signals—VEGFA—muscle cancer	0.000518	0.00532	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—FH—muscle cancer	0.0005	0.00514	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—ANGPT2—muscle cancer	0.000441	0.00453	CbGpPWpGaD
L-Citrulline—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	0.000434	0.00446	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—FOXO4—muscle cancer	0.000389	0.00399	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—PTGS2—muscle cancer	0.000366	0.00375	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—FH—muscle cancer	0.000347	0.00356	CbGpPWpGaD
L-Citrulline—NOS2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	0.000346	0.00355	CbGpPWpGaD
L-Citrulline—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000342	0.00351	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—ANGPT2—muscle cancer	0.000332	0.00341	CbGpPWpGaD
L-Citrulline—NOS1—Alzheimers Disease—TP53—muscle cancer	0.0003	0.00308	CbGpPWpGaD
L-Citrulline—NOS3—SHP2 signaling—VEGFA—muscle cancer	0.000298	0.00306	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—FOXO1—muscle cancer	0.000287	0.00295	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—MED12—muscle cancer	0.000283	0.0029	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—PTGS2—muscle cancer	0.000276	0.00283	CbGpPWpGaD
L-Citrulline—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—muscle cancer	0.000262	0.00269	CbGpPWpGaD
L-Citrulline—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—muscle cancer	0.000258	0.00265	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—ANGPT2—muscle cancer	0.000258	0.00265	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—ENO2—muscle cancer	0.000258	0.00265	CbGpPWpGaD
L-Citrulline—NOS1—Spinal Cord Injury—TP53—muscle cancer	0.000218	0.00223	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—IGF2—muscle cancer	0.000214	0.0022	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—MED12—muscle cancer	0.000196	0.00201	CbGpPWpGaD
L-Citrulline—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	0.000182	0.00187	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—ENO2—muscle cancer	0.000179	0.00183	CbGpPWpGaD
L-Citrulline—NOS3—Signaling by VEGF—VEGFA—muscle cancer	0.000172	0.00177	CbGpPWpGaD
L-Citrulline—NOS2—Spinal Cord Injury—TP53—muscle cancer	0.000164	0.00169	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—IGF2—muscle cancer	0.000162	0.00166	CbGpPWpGaD
L-Citrulline—NOS1—Disease—ENO2—muscle cancer	0.000159	0.00163	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KIDINS220—muscle cancer	0.000157	0.00161	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—FH—muscle cancer	0.000151	0.00155	CbGpPWpGaD
L-Citrulline—NOS1—Disease—HMGA1—muscle cancer	0.000144	0.00148	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FOXO4—muscle cancer	0.000129	0.00133	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—IGF2—muscle cancer	0.000125	0.00129	CbGpPWpGaD
L-Citrulline—NOS2—Disease—ENO2—muscle cancer	0.00012	0.00123	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HMGA1—muscle cancer	0.000109	0.00112	CbGpPWpGaD
L-Citrulline—NOS2—Circadian rythm related genes—TP53—muscle cancer	0.000107	0.0011	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FOXO4—muscle cancer	9.75e-05	0.001	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FOXO1—muscle cancer	9.55e-05	0.00098	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ENO2—muscle cancer	9.29e-05	0.000954	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—VEGFA—muscle cancer	8.98e-05	0.000923	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—PTGS2—muscle cancer	8.98e-05	0.000922	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—MED12—muscle cancer	8.53e-05	0.000876	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HMGA1—muscle cancer	8.44e-05	0.000867	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ENO2—muscle cancer	7.78e-05	0.000799	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FOXO4—muscle cancer	7.57e-05	0.000777	CbGpPWpGaD
L-Citrulline—NOS1—Disease—KIT—muscle cancer	7.27e-05	0.000747	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FOXO1—muscle cancer	7.2e-05	0.000739	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—TP53—muscle cancer	6.79e-05	0.000697	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—VEGFA—muscle cancer	6.78e-05	0.000696	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTGS2—muscle cancer	6.22e-05	0.000639	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTCH1—muscle cancer	6.16e-05	0.000633	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MDM2—muscle cancer	5.73e-05	0.000588	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FOXO1—muscle cancer	5.59e-05	0.000574	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTGS2—muscle cancer	5.52e-05	0.000567	CbGpPWpGaD
L-Citrulline—NOS2—Disease—KIT—muscle cancer	5.49e-05	0.000563	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FOXO4—muscle cancer	5.3e-05	0.000544	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—VEGFA—muscle cancer	5.26e-05	0.00054	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CNR1—muscle cancer	5.2e-05	0.000534	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—TP53—muscle cancer	5.12e-05	0.000526	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MDM2—muscle cancer	4.32e-05	0.000444	CbGpPWpGaD
L-Citrulline—NOS3—Disease—KIT—muscle cancer	4.26e-05	0.000437	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IGF2—muscle cancer	4.25e-05	0.000437	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTGS2—muscle cancer	4.17e-05	0.000428	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—TP53—muscle cancer	3.98e-05	0.000408	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FOXO1—muscle cancer	3.91e-05	0.000402	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MDM2—muscle cancer	3.35e-05	0.000345	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTGS2—muscle cancer	3.23e-05	0.000332	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KIT—muscle cancer	2.98e-05	0.000306	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTGS2—muscle cancer	2.71e-05	0.000278	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MDM2—muscle cancer	2.35e-05	0.000241	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VEGFA—muscle cancer	1.78e-05	0.000183	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TP53—muscle cancer	1.35e-05	0.000138	CbGpPWpGaD
